The metabolism of polyphosphoinositides in hen brain and sciatic nerve.
1. The distribution of individual phospholipids was determined in hen brain and compared with that in sciatic nerve obtained in a previous investigation. Sciatic nerve is more enriched in the myelinic phospholipids ethanolamine plasmalogen, phosphatidylserine and sphingomyelin, but it contains relatively less triphosphoinositide, and much less diphosphoinositide, than the brain. 2. The course of incorporation of intraperitoneally injected (32)P into the acid-soluble phosphorus, phosphoinositides and total phospholipids of hen brain and sciatic nerve was followed. Although the maximum specific radioactivity in sciatic nerve of acid-soluble phosphorus is 4.5 times, and that of triphosphoinositide six times, that in the brain, the relative rate of triphosphoinositide phosphorus synthesis per gram of brain is three times that in sciatic nerve. 3. Administration of the demyelinating agent tri-o-cresyl phosphate to hens has no significant effect on the amounts or the rate of (32)P incorporation into the total phospholipids of the sciatic nerve. However, the rate of incorporation of (32)P into triphosphoinositide, although not its concentration, is raised from the first day after administration of the drug and remains thus 13 and 23 days later. 4. The incorporation of (32)P into polyphosphoinositides of hen brain slices in vitro was studied. The recovery of triphosphoinositide from the slices is markedly increased in the presence of EDTA, although the rate of incorporation of (32)P is unaffected. The incorporation of (32)P is dependent on the presence of Mg(2+) and Ca(2+) in the medium, and is decreased when Na(+) is replaced with K(+) or cholinium ions.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D002118:Calcium / Q000494:pharmacology; D002645:Chickens; D004492:Edetic Acid / Q000494:pharmacology; D066298:In Vitro Techniques; D007274:Injections, Intraperitoneal; D008274:Magnesium / Q000494:pharmacology; D010714:Phosphatidylethanolamines / Q000032:analysis; D010716:Phosphatidylinositols / Q000032:analysis / Q000378:metabolism*; D010759:Phosphorus Isotopes; D010955:Plasmalogens / Q000032:analysis; D011188:Potassium / Q000494:pharmacology; D012584:Sciatic Nerve / Q000032:analysis / Q000378:metabolism*; D012964:Sodium / Q000494:pharmacology; D013109:Sphingomyelins / Q000032:analysis; D013997:Time Factors
D010714:Phosphatidylethanolamines; D010716:Phosphatidylinositols; D010759:Phosphorus Isotopes; D010955:Plasmalogens; D013109:Sphingomyelins; D004492:Edetic Acid; D012964:Sodium; D008274:Magnesium; D011188:Potassium; D002118:Calcium